Pasithea Therapeutics Corp (KTTA) insider trading
Every open-market stock purchase and sale by Pasithea Therapeutics Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $203K over the last 12 months (4 buys).
- Last insider buy: Coastlands Capital LP (10% owner), $53K, 4 months ago.
Last 12 months: insiders bought $203K (4 buys) and sold $0 (0 sales). Last close $0.58 on Jun 4, 2026.
Recent KTTA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | Coastlands Capital LP (10% owner) | Bought | $53K |
| May 1, 2026 | Simon Dumesnil (Director) | Bought (not open market) | — |
| May 1, 2026 | Daniel H Schneiderman (CFO) | Bought (not open market) | — |
| May 1, 2026 | Alfred J Novak (Director) | Bought (not open market) | — |
| May 1, 2026 | Tiago Marques (CEO) | Bought (not open market) | — |
| May 1, 2026 | Emer Leahy (Director) | Bought (not open market) | — |
| May 1, 2026 | Kartik Krishnan (C-suite exec) | Bought (not open market) | — |
| May 1, 2026 | Lawrence Steinman (Director) | Bought (not open market) | — |
| Nov 28, 2025 | Lawrence Steinman (Director) | Bought | $100K |
| Nov 28, 2025 | Emer Leahy (Director) | Bought (not open market) | $25K |
| Nov 28, 2025 | Tiago Marques (CEO) | Bought | $25K |
| Nov 28, 2025 | Simon Dumesnil (Director) | Bought | $25K |
| Nov 28, 2025 | Daniel H Schneiderman (CFO) | Bought (not open market) | $20K |
| Oct 24, 2025 | Lawrence Steinman (Director) | Bought (not open market) | — |
| Oct 24, 2025 | Daniel H Schneiderman (CFO) | Bought (not open market) | — |
| Oct 24, 2025 | Simon Dumesnil (Director) | Bought (not open market) | — |
| Oct 24, 2025 | Emer Leahy (Director) | Bought (not open market) | — |
| Oct 24, 2025 | Tiago Marques (CEO) | Bought (not open market) | — |
| Oct 24, 2025 | Alfred J Novak (Director) | Bought (not open market) | — |
Who's trading KTTA
- Coastlands Capital LP, 10% owner: bought $53K (1 buy), last Jun 17, 2026
- Simon Dumesnil, Director: bought $25K (1 buy), last May 1, 2026
- Kartik Krishnan, C-suite exec: other filings, last May 1, 2026
- Emer Leahy, Director: other filings, last May 1, 2026
- Tiago Marques, CEO: bought $25K (1 buy), last May 1, 2026
- Alfred J Novak, Director: other filings, last May 1, 2026
- Lawrence Steinman, Director: bought $100K (1 buy), last May 1, 2026
- Daniel H Schneiderman, CFO: other filings, last May 1, 2026
Get free alerts when an insider at Pasithea Therapeutics Corp files a new trade →